CHANA MAX: Open Payments
NPI 1174194781 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 6 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $350 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 1 | $130 |
| ABBVIE INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Sage Therapeutics, LLC | 1 | $120 |
Products named: PYRUKYND, VRAYLAR, Ozempic, Nayzilam, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
